Erste Asset Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Erste Asset Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,700	Closed	-$306K	–	565
2024 Q1	$306K	Hold	8,700	–	–	﹤0.01%	459
2023 Q4	$304K	Hold	8,700	–	–	﹤0.01%	460
2023 Q3	$158K	Hold	8,700	–	–	﹤0.01%	489
2023 Q2	$224K	Hold	8,700	–	–	﹤0.01%	484
2023 Q1	$161K	Hold	8,700	–	–	﹤0.01%	509
2022 Q4	$209K	Hold	8,700	–	–	﹤0.01%	492
2022 Q3	$152K	Hold	8,700	–	–	﹤0.01%	509
2022 Q2	$104K	Hold	8,700	–	–	﹤0.01%	537
2022 Q1	$194K	Buy	+8,700	New	+$222K	﹤0.01%	509

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Erste Asset Management's INBX Position: Q2 2024 in Review

Erste Asset Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 8,700 shares — an estimated $306K sold.

Erste Asset Management first reported a position in INBX in Q1 2022 and held it in 9 quarters. The position peaked at $306K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Erste Asset Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Erste Asset Management sold 8,700 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $306K.
Erste Asset Management first reported a position in Inhibrx, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
Erste Asset Management's Inhibrx, Inc. Common Stock position peaked at $306K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Erste Asset Management's 13F filing for Q2 2024, filed 26 Nov 2024.